Nickolay Voronin

HealthCor Partners Fund LP invests in companies located in the US. The fund targets the companies operating in the fields of healthcare and life sciences. The fund provides financing in the form of equity and debt for restructurings, recapitalizations, later stage requirements, buyouts , acquisitions and other special situations with an investment size ranges between $5 million to $25 million in each portfolio company . The fund makes minority and/or control investments. The fund also invests in public companies.

ReShape Medical, Inc. develops non-surgical medical devices for the treatment of obesity. The company is headquartered in San Mateo, CA.

HealthCor Group LLC provides investment advisory services to private investment funds. The company is headquartered in New York, NY.

HealthCor Partners Fund II LP invests primarily in later-stage developmental and growing (private or publicly traded) mid-sized companies across all sectors of the healthcare and life sciences industry. The fund makes minority and controlling investments. It backs experienced management teams in leveraged buyouts and in creating growing companies through a series of acquisitions. It also selectively invests in restructurings, recapitalizations and other special situations involving more established healthcare companies. It makes equity and equity related investments between USD 5 - 25 million in each portfolio company.

ApaTech Ltd. develops synthetic bone graft technology. It specializes in producing synthetic bone repair material. The company has developed a novel silicate substituted calcium phosphate bone graft material, Actifuse, which underpins the company's leadership in applying the science of silicon to bone graft technologies. Actifuse is the first of a new class of synthetic bone graft materials that combine osteoconductive, osteostimulatory and bioactive qualities resulting in accelerated bone growth. The company was founded in 2001 and is headquartered in Elstree, UK.

Velcera LLC operates as a pharmaceutical company. It focuses on innovation in the expanding pet health market and its product development targets pet medicines in pain management, anti-allergy and parasiticides that can provide superior convenience and greater compliance than traditional products. The firm is developing Promist, a transmucosal oral mist drug delivery technology for use in companion animals. It is also developing Promist products, including VEL504 for pain management and VEL502 for treating allergic atopic dermatitis in canines. The company was founded ion February 18, 2010 and is headquartered in Yardley, PA.

The American Ophthalmological Society is an organization that aims to promote excellence in patient care, education, and research in the field of ophthalmology. The society is based in San Francisco, CA, and was founded in 1864 by Edward Delafield, Daniel Bennett St. John Roosa, and Henry Noyes. The private company addresses essential issues in medicine and advance the art and science of ophthalmology. The society holds annual meetings every third week of May each year, and they offer travel grants to non-members who wish to attend. Membership nominations are accepted until April 30th each year.

HealthCor Partners Management LP (HealthCor Partners) is a private equity subsidiary of HealthCor Group LLC founded in 2007 by Michael Yehuda Mashaal, Arthur Bruce Cohen and Joseph Patrick Healey. The firm is headquartered in New York.

ReShape Weightloss, Inc. operates as a medical device company, which focuses on technology to treat obesity and metabolic diseases. It operates through the following segments: Lap-Band, ReShape Vest and ReShape vBloc. The company was founded in December 2002 and is headquartered in San Clemente, CA.

SKS Ocular, LLC is a private ophthalmology company incubator that uses state-of-the-art research and development technologies to discover and advance novel therapeutics through preclinical or clinical proof of concept.

Part of ProScan Imaging LLC, Jason S. Slakter MD PC is an ophthalmology imaging core lab. The company is based in Great Neck, NY. The company was founded in 1998 by Jason Scott Slakter and Jeffrey Schneebaum. Jason Scott Slakter has been the CEO since 1998. Jason S. Slakter MD was acquired by WorldCare Clinical LLC on September 03, 2021.